RecruitingNot ApplicableNCT04278690

Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit

A Randomized, Controlled Study of a Health Literacy-informed Technology-based Approach to Support Safe Medication Use by Parents After Discharge of Infants From the Neonatal Intensive Care Unit.


Sponsor

NYU Langone Health

Enrollment

425 participants

Start Date

Mar 10, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

This is a randomized controlled study of parents of children to be discharged from the neonatal intensive care unit at Bellevue and Elmhurst hospitals. A total of 425 subjects will be recruited across two sites over preparatory phases and two primary study phases.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • English or Spanish-speaking
  • 18 years of age and older
  • Child discharged home with a Rx for >1 daily liquid medication (other than multivitamin)
  • Primary person who will administers child's medications.
  • Willingness and ability to participate

Exclusion Criteria6

  • Does not have a working phone number
  • Does not have access to internet (via computer/smartphone)
  • Does not have a mobile phone that receives texts.
  • Not able to return to the hospital for their child's follow-up visit
  • Visual acuity worse than 20/50 according to the Rosenbaum Pocket Screener
  • Uncorrectable hearing impairment

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERHELPix

HELPix parents will receive usual care as above, after which trained staff will generate HELPix patient-/regimen-specific medication instruction sheets and review them with the parent. Instruction sheets include optimized instructions (mL-only, doses appropriately rounded, visuals of recommended tool (e.g. 1-mL syringe best for doses of \<1 mL), explicit frequency information (e.g. 'morning and night' instead of '2x/day') reinforced by pictograms (e.g. sun/moon icons)). For each medication, staff will: 1) review the dose (refer to the pictographic dose diagram, which illustrates optimal dosing tool filled to correct amount), 2) demonstrate the dose using optimal dosing tool, 3) ask parent to 'teachback'/'showback' dose (e.g. parent shows provider how much they would give by pulling back plunger on syringe to right level), 4) provide optimal dosing tool for the parent to take home. We anticipate this process will take \~5-10 minutes.

OTHERHELPix+Tech

After parent receives usual care and HELPix , trained staff will walk parent through the app on-boarding process to overcome initial barriers to use. Steps: 1) Parent texted link to personalized on-line instructions. 2) Parent clicks link to app. For each medicine: A. Dosing module with optimized instructions (c/w HELPix); parent teachback/showback of dose B. Frequency module supports simplified, explicit intervals (e.g. 'morning and night'), parent chooses convenient times (text reminders sent based on preferences). Time for TECH depends on # medicines and parent baseline knowledge; structured protocol used to see # teachback rounds needed .


Locations(1)

NYU Langone Health

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04278690